Expression of alternatively spliced Runx2 in multiple myeloma patients and a shift in expression in response to thalidomide treatment.

被引：0
|
作者：
Bose, N
Bergemann, H
Westendorf, JJ
Rajkumar, SV
Masellis, AM
机构：
[1] Virginia Piper Canc Inst, Minneapolis, MN USA
[2] Univ Minnesota, Orthopaed Surg & Canc Ctr, Minneapolis, MN 55455 USA
[3] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2003年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S310 / S310
页数：1
相关论文
共 50 条
  • [41] Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment
    Popek-Marciniec, Sylwia
    Styk, Wojciech
    Wojcierowska-Litwin, Magdalena
    Chocholska, Sylwia
    Szudy-Szczyrek, Aneta
    Samardakiewicz, Marzena
    Swiderska-Kolacz, Grazyna
    Czerwik-Marcinkowska, Joanna
    Zmorzynski, Szymon
    CANCERS, 2023, 15 (19)
  • [42] NQO1*2 polymorphism and response to treatment in patients with multiple myeloma
    Buda, Gabriele
    Maggini, Valentina
    Galimberti, Sara
    Barale, Roberto
    Rossi, Anna Maria
    Petrini, Mario
    LEUKEMIA RESEARCH, 2007, 31 (08) : 1029 - 1030
  • [43] Clinical Features and Treatment Response in Patients with Multiple Myeloma and CD20 Expression: Real-Life Experience of the Centro-Italy Multiple Myeloma Macroregional District
    Fiorini, Alessia
    Panichi, Valentina
    Chavez, Maria Gabriela
    Cordone, Iole
    Montanaro, Guido
    Fazio, Francesca
    Bassi, Loredana
    Tomarchio, Valeria
    Sbraga, Edoardo
    Poscente, Monica
    Merola, Roberta
    De Propris, Maria Stefania
    Mengarelli, Andrea
    Licci, Stefano
    Giancola, Raffaella
    Latagliata, Roberto
    Annibali, Ombretta
    Rago, Angela
    Fioritoni, Francesca
    Petrucci, Maria Teresa
    Andriani, Alessandro
    BLOOD, 2022, 140 : 12549 - 12550
  • [44] Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide–dexamethasone incorporated into double autologous transplantation
    Carolina Terragna
    Matteo Renzulli
    Daniel Remondini
    Enrico Tagliafico
    Francesco Di Raimondo
    Francesca Patriarca
    Giovanni Martinelli
    Enrica Roncaglia
    Luciano Masini
    Patrizia Tosi
    Elena Zamagni
    Paola Tacchetti
    Antonio Ledda
    Annamaria Brioli
    Emanuele Angelucci
    Nicoletta Testoni
    Giulia Marzocchi
    Piero Galieni
    Alessandro Gozzetti
    Marina Martello
    Flores Dico
    Katia Mancuso
    Michele Cavo
    Annals of Hematology, 2013, 92 : 1271 - 1280
  • [45] Desmoglein-2 expression is an independent predictor of poor prognosis patients with multiple myeloma
    Ebert, Lisa M.
    Vandyke, Kate
    Johan, M. Zahied
    DeNichilo, Mark
    Tan, Lih Y.
    Myo Min, Kay K.
    Weimann, Benjamin M.
    Ebert, Brenton W.
    Pitson, Stuart M.
    Zannettino, Andrew C. W.
    Wallington-Beddoe, Craig T.
    Bonder, Claudine S.
    MOLECULAR ONCOLOGY, 2022, 16 (06) : 1221 - 1240
  • [46] P-glycoprotein expression, p53 status and treatment response in multiple myeloma.
    Scott, FM
    Mackie, MJ
    Harrison, DJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 308 - 308
  • [47] The mRNA Expression and Regulation of Glucocorticoid Receptor Isoforms Associatedwith Response of Multiple Myeloma Treatedwith a Glucocorticoids-Dependent Regimen of Dexamethasone, Bortezomib and Thalidomide
    Guan, Yanchun
    Si, Yang
    Cai, Wei
    Ma, Liangliang
    Fang, Meiyun
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2021, 51 (06): : 805 - 817
  • [48] RANKL, OPG, and RUNX2 expression and epigenetic modifications in giant cell tumour of bone in 32 patients association with clinicopathological characteristics and recurrence
    Amri, R.
    Chelly, A.
    Ayedi, M.
    Rebaii, M. A.
    Aifa, S.
    Masmoudi, S.
    Keskes, H.
    BONE & JOINT RESEARCH, 2024, 13 (02): : 83 - 90
  • [49] Clinical significance of RUNX2 expression in patients with nonsmall cell lung cancer: a 5-year follow-up study
    Li, Hong
    Zhou, Ren-Jie
    Zhang, Guo-Qiang
    Xu, Jian-Ping
    TUMOR BIOLOGY, 2013, 34 (03) : 1807 - 1812
  • [50] Prediction of response to primary therapy with thalidomide-dexamethasone(Thal-DEX) for newly diagnosed multiple myeloma by gene expression profiling (GEP)
    Terragna, C.
    Renzulli, M.
    Remondini, D.
    Tagliafico, E.
    Roncaglia, E.
    Tosi, P.
    Zamagni, E.
    Tacchetti, P.
    Perrone, G.
    Ceccolini, M.
    Brioli, A. M.
    Martinelli, G.
    Baccarani, M.
    Cavo, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 177 - 177
12345